SCHEMBL6670076

SCHEMBL6670076

CCN(CC)CCN.O=C(N[C@@H](CCCNCc1ccccn1)C(=O)O)c1ccc(CNCc2ccccn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.48
FOLH1 Q04609 1/20 0.39
DHFR P00374 2/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
CA2 P00918 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA9 Q16790 1/20 0.38
TYMS P04818 1/20 0.38
PTPN1 P18031 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FPGS Q05932 1/20 0.38
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
GPR132 Q9UNW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671573 0.90 CXCR4 (0.51) CXCR4FOLH1DHFRKMT2ALMNA
SCHEMBL6018116 0.89 CXCR4 (0.53) CXCR4FOLH1KMT2ALMNANPC1
SCHEMBL27566287 0.89 CXCR4 (0.53) CXCR4FOLH1KMT2ALMNANPC1
SCHEMBL6018244 0.86 CXCR4 (0.51) CXCR4KMT2ALMNANPC1POLB
SCHEMBL27568576 0.85 CXCR4 (0.47) CXCR4FOLH1DHFRKMT2ACA2
SCHEMBL6667469 0.85 CXCR4 (0.47) CXCR4FOLH1DHFRKMT2ACA2
Phenylhydrazine SCHEMBL6690774 0.84 CXCR4 (0.50) CXCR4FOLH1DHFRKMT2ALMNA
SCHEMBL6018220 0.84 CXCR4 (0.51) CXCR4FOLH1DHFRKMT2ALMNA
SCHEMBL27597836 0.82 CXCR4 (0.49) CXCR4FOLH1DHFRKMT2ACA2
SCHEMBL6669795 0.82 CXCR4 (0.47) CXCR4FOLH1CA2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound KUREHA CORPORATION (JP) 2004-08-12 US disclosed
EP-1389460-A1 CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND Kureha Chemical Industry Co., Ltd. (JP) 2004-02-18 EP disclosed
EP-1273571-A1 NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME Kureha Chemical Industry Co., Ltd. (JP) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound CXCR4, CXCR1, CXCR2 CXCR4 1/4885FOLH1 2694/4885DHFR 4201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.